Viridian Therapeutics, Inc. (VRDN)
17.52
-1.23
(-6.56%)
USD |
NASDAQ |
May 06, 16:00
17.52
0.00 (0.00%)
After-Hours: 20:00
Viridian Therapeutics EPS Diluted (Quarterly) : 0.00 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Boston Scientific Corp. | 0.897 |
| Marker Therapeutics, Inc. | -0.1022 |
| Plus Therapeutics, Inc. | -1.03 |
| Nutriband, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -104.90M |
| Revenue (Quarterly) | 0.141M |
| Total Expenses (Quarterly) | 0.141M |
| Enterprise Value | 1.354B |
| Gross Profit Margin (Quarterly) | 14.18% |
| Profit Margin (Quarterly) | -74.40K% |
| Earnings Yield | -15.63% |